Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KEYNOTE-495/KeyImPaCT: Phase 2 biomarker-directed study of pembrolizumab-based therapy for non-small cell lung cancer
    Meeting Abstract

    Gutierrez, M.; Hellmann, M.; Gubens, M.; Aggarwal, C.; Tan, D.; Felip, E.; Lam, W.; Chiu, J. W. Y.; Lee, J.; Yang, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers
    Meeting Abstract

    Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Antitumor activity of the oral EGFR/HER2 inhibitor TAK-788 in NSCLC with EGFR exon 20 insertions
    Meeting Abstract

    Riely, G.; Neal, J.; Camidge, D. R.; Spira, A.; Piotrowska, Z.; Horn, L.; Costa, D.; Tsao, A.; Patel, J.; Gadgeel, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Preliminary phase 1 results of U3-1402: A novel HER3-targeted antibody-drug conjugate-in EGFR TKI-resistant, EGFR-mutant NSCLC
    Meeting Abstract

    Yu, H.; Johnson, M.; Steuer, C.; Vigliotti, M.; Chen, S.; Kamai, Y.; Yu, C.; Janne, P.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Wozniak, A.; Schneider, B.; Kalemkerian, G.; Daly, R.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles
    Meeting Abstract

    Riely, G.; Lovly, C.; Messina, C.; Bienert, S.; Alexander, K.; Pao, W.; Magee, K.; Baxi, S.; Doebele, R.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A multicenter phase 1/2a trial of CLN-081 in NSCLC with EGFR exon 20 insertion mutations
    Meeting Abstract

    Piotrowska, Z.; Planchard, D.; Clancy, M.; Witter, D.; Zawel, L.; Yu, H.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Novel germline mutations in DNA-damage repair and DNA replication identified in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Guo, R.; Duboff, M.; Kris, M.; Ladanyi, M.; Mandelker, D.; Zauderer, M.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Entrectinib in patients with ROS1-positive NSCLC or NTRK fusion-positive solid tumors with CNS metastases
    Meeting Abstract

    Paz-Ares, L.; Dziadziuszko, R.; Drilon, A.; John, T.; Krebs, M.; Demetri, G.; Shaw, A.; Siena, S.; Wolf, J.; Farago, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Generation and characterization of novel preclinical disease models of NSCLC with NRG1 rearrangements to improve therapy
    Meeting Abstract

    Gladstone, E.; Vojnic, M.; Offin, M.; Delasos, L.; Lui, A.; Siau, E.; Sato, H.; Benayed, R.; Kurth, R.; Mattar, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save